Literature DB >> 8394711

Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum.

E Götz1, T J Feuerstein, A Lais, D K Meyer.   

Abstract

The gamma-aminobutyric acid (GABA) analogue gabapentin (CAS 60142-96-3) has a strong anticonvulsant activity in patients, but its mechanism of action is unknown. In the present study, the effect of gabapentin was tested on the release of [3H]GABA from neostriatal slices incubated in vitro. Gabapentin displayed a bell-shaped concentration-response curve. When used at the therapeutically relevant concentration of 1 mumol/l, it nearly doubled the release of [3H]GABA, while it was without effects at concentrations of 0.1 and 10 mumol/l, respectively. The enhancing effect was blocked by the GABAA receptor antagonists picrotoxin (5 mumol/l) and bicucullin (100 mumol/l). When the slices were pre-incubated with the agonist muscimol (1 mumol/l) to occupy the GABAA receptors, 1 mumol/l gabapentin no longer enhanced the release of [3H]GABA. It is concluded that gabapentin can enhance the release of [3H]GABA, when used at a therapeutically relevant concentration. GABAA receptors are involved in this effect which may contribute to the agent's anticonvulsant activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394711

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  14 in total

1.  Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats.

Authors:  Małgorzata Filip; Małgorzata Frankowska; Magdalena Zaniewska; Anna Gołda; Edmund Przegaliński; Jerzy Vetulani
Journal:  Psychopharmacology (Berl)       Date:  2007-01-26       Impact factor: 4.530

2.  Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain.

Authors:  M J Field; J Hughes; L Singh
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 3.  Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.

Authors:  Cory Toth
Journal:  Ther Adv Drug Saf       Date:  2014-02

Review 4.  Pharmacologic treatment of neuropathic pain.

Authors:  M S Wallace
Journal:  Curr Pain Headache Rep       Date:  2001-04

Review 5.  Adverse reactions to new anticonvulsant drugs.

Authors:  I C Wong; S D Lhatoo
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

Review 6.  CNS adverse events associated with antiepileptic drugs.

Authors:  Gina M Kennedy; Samden D Lhatoo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

7.  Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats.

Authors:  Xiao-Qing Peng; Xia Li; Jie Li; P Veeraraghavan Ramachandran; Pravin D Gagare; Debarshi Pratihar; Charles R Ashby; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

8.  Cellular and behavioral interactions of gabapentin with alcohol dependence.

Authors:  Marisa Roberto; Nicholas W Gilpin; Laura E O'Dell; Maureen T Cruz; Andrew C Morse; George R Siggins; George F Koob
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

Review 9.  Development of pharmacotherapies for drug addiction: a Rosetta stone approach.

Authors:  George F Koob; G Kenneth Lloyd; Barbara J Mason
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

Review 10.  Gabapentin for the treatment of alcohol use disorder.

Authors:  Barbara J Mason; Susan Quello; Farhad Shadan
Journal:  Expert Opin Investig Drugs       Date:  2017-12-23       Impact factor: 6.206

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.